DRUG · Unmapped registry intervention
Repaglinide, Bupropion and SHR3680
Find medicine records ·
Find other trials using this name
Clinical trial
Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion
NCT04664725
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDrug-drug Interaction of SHR3680 With Repaglinide and Bupropion
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancer Patientsunresolved
Interventions
Sponsors & collaborators
Jiangsu HengRui Medicine Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04664725 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.